Trial · NCT01372995
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Baseline | Baseline | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. At the baseline time point, 10 patients were randomized to the placebo arm, 9 to the arm receiving 250,000 IU of Vitamin D3, and 11 to the arm receiving 500,000 of Vitamin D3. | participants | NUMBER |
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 7 | Day 7 | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. The number of participants analyzed at each time point decreased over the course of the study as participants were discharged from the hospital. | participants | NUMBER |
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 14 | Day 14 | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. The number of participants analyzed for each time point decreased over the course of the study as participants were discharged from the hospital. | participants | NUMBER |
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 21 | Day 21 | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. The number of participants analyzed at each time point decreased over the course of the study as participants were discharged from the hospital. | participants | NUMBER |
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 28 | Day 28 | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. The number of participants analyzed at each time point decreased over the course of the study as participants were discharged from the hospital. | participants | NUMBER |
| PRIMARY | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 84 | Day 84 | Blood samples were obtained every 7 days while participants remained hospitalized. Follow up discontinued once the participant was discharged from the hospital. The number of participants analyzed at each time point decreased over the course of the study as participants were discharged from the hospital. | participants | NUMBER |
| SECONDARY | Change in Plasma LL-37 Levels | Baseline, Day 7, Day 14 | For the Day 14 analysis there were 8 participants in the Placebo arm, 6 participants in the 250,000 of Vitamin D arm, and 5 participants in the 500,000 of Vitamin D arm. | ng/mL | MEDIAN |
| SECONDARY | Duration of Time on Ventilator | 12 weeks | days | MEAN | |
| SECONDARY | Duration of Time in Intensive Care Unit (ICU) | 12 weeks | days | MEAN | |
| SECONDARY | Duration of Time in Hospital | 12 weeks | days | MEAN | |
| SECONDARY | Change in Sequential Organ Failure Assessment (SOFA) Score | Baseline, Day 7 | SOFA score obtained daily while in the ICU. The portion of the study participants included in the analysis of the change in SOFA score between Baseline and Day 7 is limited to participants having values for both time points.. | units on a scale | MEAN |
| SECONDARY | Number of Hospital Acquired Infections | 12 weeks | participants | NUMBER | |
| SECONDARY | Number of Hospital Mortality Cases | 12 weeks | The number of participants in the hospital mortality analysis for the arm receiving 500,000 IU of Vitamin D3 was 10, rather than 11. | participants | NUMBER |
| SECONDARY | Day 84 Mortality | Day 84 | The number of participants in the hospital mortality analysis for the arm receiving 500,000 IU of Vitamin D3 was 10, rather than 11, as one participant withdrew. | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01372995/outcomes